Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
Status:
Terminated
Trial end date:
2020-11-19
Target enrollment:
Participant gender:
Summary
biological DMARDs may be stopped in Rheumatoid Arthritis (RA) patients treated with a
combination of synthetic DMARD plus bDMARDs which are in persistent clinical remission. The
research question of this study is, whether musculoskeletal sonography is a useful biomarker
predicting a disease flare after cessation of bDMARD therapy.